Skip to Login Skip to Content Skip to Secondary Navigation

New York: Cancer Precision Medicine: Implications for Stakeholders

Wednesday, Jun 5, 2019
6:00 PM - 8:30 PM EDT
Manatt Health, 7 Times Square. NYCMap Location
This event does not require an RSVP.

RSVP required. To register for this event, please click here.  

New York: Cancer Precision Medicine: Implications for Stakeholders
Presented by the Columbia Business School Alumni Club of New York
Wednesday, June 5, 2019 | 6–8:30 p.m.
Manatt Health, 7 Times Square. NYC  

Breakthroughs in data science and biology are helping providers and companies tailor cancer treatment more precisely, with important implications for investors, executives, and patients. Speakers are leaders in clinical diagnostics, healthcare systems, medicine, reimbursement, and therapeutic evidence generation. 


James Crawford, MD, PhD (Moderator)

Ghassan Abou-Alfa, MD, CBS '16 (MSKCC GI Oncology)

Mike KolodjiezMD  (Chief Innovation Officer, ADVI and National Medical Director, Oncology, Aetna) 

Melisa Tucker (VP, Product Development, Flatiron Health)

Burt Zweigenhalt (Managing Partner, Upstream Partners)